Journal of Translational Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2175309, encodeId=41f921e5309d0, content=偏重的研究方向：cancer therapy;肿瘤;实验验证 经验分享：已经24天了，还是editor assigned。编号9600多号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Dec 16 18:35:26 CST 2023, time=2023-12-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175811, encodeId=cfa321e581135, content=偏重的研究方向：GWAS;心血管 经验分享：记录一下这个期刊的投稿经历。 先投了BMC medicine，三天光速拒稿，再投了Genome Medicine 十天建议转投。 12月14号投这个，现在12月19号还是new submission，是不是完全不感兴趣一直拖着我了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ee9080824, createdName=ms6000001245656875, createdTime=Tue Dec 19 14:19:10 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174662, encodeId=bb3721e46621a, content=偏重的研究方向：综述 经验分享：求meta投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a299060417, createdName=ms7000000984089298, createdTime=Wed Dec 13 10:11:26 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117409, encodeId=c06d211e409ea, content=偏重的研究方向：转化医学;translational medicine 经验分享：太坑了！！！23.01.22投稿，但今天23.03.03，还在那editor assigned呢！！！！期间催了三次，分别是半月，一月和今天，都是个V开头的名字回的邮件，查了下，可能是个助理编辑，印度人，回复内容大意就是就说sorry，ok，我向上转达......然后实际啥也没干还在这editor assigned呢...再等一周，不送我就主动撤稿！！！！好气啊！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c86436029, createdName=4382035_3828, createdTime=Fri Mar 03 22:27:08 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170659, encodeId=0e2121e0659ed, content=截至日期延后两天提交有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e71b1678189, createdName=周医生8433, createdTime=Fri Nov 24 08:48:54 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167495, encodeId=af8c216e495f3, content=求助，这个杂志的new submition一般持续多久到editor assigned呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Nov 09 04:10:01 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142837, encodeId=1968214283ec4, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：今天晚上刚收到accepted的邮件，投这个杂志真的需要耐心，虽然有的人很快接收，但我等的真心累。去年11月14日投稿，到今年3月初都没消息，忍不住发邮件催稿，得到回复没有足够审稿人，他们想办法立即处理，到3月22日收到邮件大修，马不停蹄修改，4月4日修回，4月11日就显示reviews completed，然后就没消息了，催了一次说等编辑决定，2个月状态纹丝不动，到6月初又催了一次，回复跟上次一模一样，过了一天后居然又让推荐审稿人，迷之操作，看不懂了，推荐审稿人后继续等待，直到今晚突然收到邮件说接受了。等待过程比较辛苦，感觉是杂志社故意压稿，今年影响因子也降了，投此杂志的兄弟们准备好耐心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Wed Jun 14 23:51:39 CST 2023, time=2023-06-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2164215, encodeId=f8c2216421525, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：气死。等待分配编辑等了1个多月，近2月，发邮件要求退稿，才给分配了编辑。完了送外审，又快2月，说找不到审稿人，拒了。耽搁我4个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c444693051, createdName=1874229beam, createdTime=Sun Oct 22 16:45:36 CST 2023, time=2023-10-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2167525, encodeId=4857216e52535, content=偏重的研究方向：男性生殖 经验分享：记录一下这本杂志的第一次投稿，11.6投稿，目前还是new submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb5b5613243, createdName=ms5000001721638337, createdTime=Thu Nov 09 09:36:45 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2158272, encodeId=2a9521582e204, content=偏重的研究方向：肿瘤学 经验分享：大修返回去一周了还是under review,接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=ms5000000710567195, createdTime=Mon Sep 18 12:44:26 CST 2023, time=2023-09-18, status=1, ipAttribution=安徽省)]

2023-12-16 1762000651m 来自湖南省

偏重的研究方向：cancer therapy;肿瘤;实验验证
经验分享：已经24天了，还是editor assigned。编号9600多号。

40 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2175309, encodeId=41f921e5309d0, content=偏重的研究方向：cancer therapy;肿瘤;实验验证 经验分享：已经24天了，还是editor assigned。编号9600多号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Dec 16 18:35:26 CST 2023, time=2023-12-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175811, encodeId=cfa321e581135, content=偏重的研究方向：GWAS;心血管 经验分享：记录一下这个期刊的投稿经历。 先投了BMC medicine，三天光速拒稿，再投了Genome Medicine 十天建议转投。 12月14号投这个，现在12月19号还是new submission，是不是完全不感兴趣一直拖着我了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ee9080824, createdName=ms6000001245656875, createdTime=Tue Dec 19 14:19:10 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174662, encodeId=bb3721e46621a, content=偏重的研究方向：综述 经验分享：求meta投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a299060417, createdName=ms7000000984089298, createdTime=Wed Dec 13 10:11:26 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117409, encodeId=c06d211e409ea, content=偏重的研究方向：转化医学;translational medicine 经验分享：太坑了！！！23.01.22投稿，但今天23.03.03，还在那editor assigned呢！！！！期间催了三次，分别是半月，一月和今天，都是个V开头的名字回的邮件，查了下，可能是个助理编辑，印度人，回复内容大意就是就说sorry，ok，我向上转达......然后实际啥也没干还在这editor assigned呢...再等一周，不送我就主动撤稿！！！！好气啊！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c86436029, createdName=4382035_3828, createdTime=Fri Mar 03 22:27:08 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170659, encodeId=0e2121e0659ed, content=截至日期延后两天提交有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e71b1678189, createdName=周医生8433, createdTime=Fri Nov 24 08:48:54 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167495, encodeId=af8c216e495f3, content=求助，这个杂志的new submition一般持续多久到editor assigned呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Nov 09 04:10:01 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142837, encodeId=1968214283ec4, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：今天晚上刚收到accepted的邮件，投这个杂志真的需要耐心，虽然有的人很快接收，但我等的真心累。去年11月14日投稿，到今年3月初都没消息，忍不住发邮件催稿，得到回复没有足够审稿人，他们想办法立即处理，到3月22日收到邮件大修，马不停蹄修改，4月4日修回，4月11日就显示reviews completed，然后就没消息了，催了一次说等编辑决定，2个月状态纹丝不动，到6月初又催了一次，回复跟上次一模一样，过了一天后居然又让推荐审稿人，迷之操作，看不懂了，推荐审稿人后继续等待，直到今晚突然收到邮件说接受了。等待过程比较辛苦，感觉是杂志社故意压稿，今年影响因子也降了，投此杂志的兄弟们准备好耐心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Wed Jun 14 23:51:39 CST 2023, time=2023-06-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2164215, encodeId=f8c2216421525, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：气死。等待分配编辑等了1个多月，近2月，发邮件要求退稿，才给分配了编辑。完了送外审，又快2月，说找不到审稿人，拒了。耽搁我4个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c444693051, createdName=1874229beam, createdTime=Sun Oct 22 16:45:36 CST 2023, time=2023-10-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2167525, encodeId=4857216e52535, content=偏重的研究方向：男性生殖 经验分享：记录一下这本杂志的第一次投稿，11.6投稿，目前还是new submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb5b5613243, createdName=ms5000001721638337, createdTime=Thu Nov 09 09:36:45 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2158272, encodeId=2a9521582e204, content=偏重的研究方向：肿瘤学 经验分享：大修返回去一周了还是under review,接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=ms5000000710567195, createdTime=Mon Sep 18 12:44:26 CST 2023, time=2023-09-18, status=1, ipAttribution=安徽省)]

2023-12-19 ms6000001245656875 来自广东省

偏重的研究方向：GWAS;心血管
经验分享：记录一下这个期刊的投稿经历。
先投了BMC medicine，三天光速拒稿，再投了Genome Medicine 十天建议转投。
12月14号投这个，现在12月19号还是new submission，是不是完全不感兴趣一直拖着我了。

86 0

[GetPortalCommentsPageByObjectIdResponse(id=2175309, encodeId=41f921e5309d0, content=偏重的研究方向：cancer therapy;肿瘤;实验验证 经验分享：已经24天了，还是editor assigned。编号9600多号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Dec 16 18:35:26 CST 2023, time=2023-12-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175811, encodeId=cfa321e581135, content=偏重的研究方向：GWAS;心血管 经验分享：记录一下这个期刊的投稿经历。 先投了BMC medicine，三天光速拒稿，再投了Genome Medicine 十天建议转投。 12月14号投这个，现在12月19号还是new submission，是不是完全不感兴趣一直拖着我了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ee9080824, createdName=ms6000001245656875, createdTime=Tue Dec 19 14:19:10 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174662, encodeId=bb3721e46621a, content=偏重的研究方向：综述 经验分享：求meta投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a299060417, createdName=ms7000000984089298, createdTime=Wed Dec 13 10:11:26 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117409, encodeId=c06d211e409ea, content=偏重的研究方向：转化医学;translational medicine 经验分享：太坑了！！！23.01.22投稿，但今天23.03.03，还在那editor assigned呢！！！！期间催了三次，分别是半月，一月和今天，都是个V开头的名字回的邮件，查了下，可能是个助理编辑，印度人，回复内容大意就是就说sorry，ok，我向上转达......然后实际啥也没干还在这editor assigned呢...再等一周，不送我就主动撤稿！！！！好气啊！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c86436029, createdName=4382035_3828, createdTime=Fri Mar 03 22:27:08 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170659, encodeId=0e2121e0659ed, content=截至日期延后两天提交有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e71b1678189, createdName=周医生8433, createdTime=Fri Nov 24 08:48:54 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167495, encodeId=af8c216e495f3, content=求助，这个杂志的new submition一般持续多久到editor assigned呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Nov 09 04:10:01 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142837, encodeId=1968214283ec4, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：今天晚上刚收到accepted的邮件，投这个杂志真的需要耐心，虽然有的人很快接收，但我等的真心累。去年11月14日投稿，到今年3月初都没消息，忍不住发邮件催稿，得到回复没有足够审稿人，他们想办法立即处理，到3月22日收到邮件大修，马不停蹄修改，4月4日修回，4月11日就显示reviews completed，然后就没消息了，催了一次说等编辑决定，2个月状态纹丝不动，到6月初又催了一次，回复跟上次一模一样，过了一天后居然又让推荐审稿人，迷之操作，看不懂了，推荐审稿人后继续等待，直到今晚突然收到邮件说接受了。等待过程比较辛苦，感觉是杂志社故意压稿，今年影响因子也降了，投此杂志的兄弟们准备好耐心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Wed Jun 14 23:51:39 CST 2023, time=2023-06-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2164215, encodeId=f8c2216421525, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：气死。等待分配编辑等了1个多月，近2月，发邮件要求退稿，才给分配了编辑。完了送外审，又快2月，说找不到审稿人，拒了。耽搁我4个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c444693051, createdName=1874229beam, createdTime=Sun Oct 22 16:45:36 CST 2023, time=2023-10-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2167525, encodeId=4857216e52535, content=偏重的研究方向：男性生殖 经验分享：记录一下这本杂志的第一次投稿，11.6投稿，目前还是new submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb5b5613243, createdName=ms5000001721638337, createdTime=Thu Nov 09 09:36:45 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2158272, encodeId=2a9521582e204, content=偏重的研究方向：肿瘤学 经验分享：大修返回去一周了还是under review,接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=ms5000000710567195, createdTime=Mon Sep 18 12:44:26 CST 2023, time=2023-09-18, status=1, ipAttribution=安徽省)]

2023-12-13 ms7000000984089298 来自广东省

偏重的研究方向：综述
经验分享：求meta投稿经验

18 0

[GetPortalCommentsPageByObjectIdResponse(id=2175309, encodeId=41f921e5309d0, content=偏重的研究方向：cancer therapy;肿瘤;实验验证 经验分享：已经24天了，还是editor assigned。编号9600多号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Dec 16 18:35:26 CST 2023, time=2023-12-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175811, encodeId=cfa321e581135, content=偏重的研究方向：GWAS;心血管 经验分享：记录一下这个期刊的投稿经历。 先投了BMC medicine，三天光速拒稿，再投了Genome Medicine 十天建议转投。 12月14号投这个，现在12月19号还是new submission，是不是完全不感兴趣一直拖着我了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ee9080824, createdName=ms6000001245656875, createdTime=Tue Dec 19 14:19:10 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174662, encodeId=bb3721e46621a, content=偏重的研究方向：综述 经验分享：求meta投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a299060417, createdName=ms7000000984089298, createdTime=Wed Dec 13 10:11:26 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117409, encodeId=c06d211e409ea, content=偏重的研究方向：转化医学;translational medicine 经验分享：太坑了！！！23.01.22投稿，但今天23.03.03，还在那editor assigned呢！！！！期间催了三次，分别是半月，一月和今天，都是个V开头的名字回的邮件，查了下，可能是个助理编辑，印度人，回复内容大意就是就说sorry，ok，我向上转达......然后实际啥也没干还在这editor assigned呢...再等一周，不送我就主动撤稿！！！！好气啊！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c86436029, createdName=4382035_3828, createdTime=Fri Mar 03 22:27:08 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170659, encodeId=0e2121e0659ed, content=截至日期延后两天提交有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e71b1678189, createdName=周医生8433, createdTime=Fri Nov 24 08:48:54 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167495, encodeId=af8c216e495f3, content=求助，这个杂志的new submition一般持续多久到editor assigned呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Nov 09 04:10:01 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142837, encodeId=1968214283ec4, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：今天晚上刚收到accepted的邮件，投这个杂志真的需要耐心，虽然有的人很快接收，但我等的真心累。去年11月14日投稿，到今年3月初都没消息，忍不住发邮件催稿，得到回复没有足够审稿人，他们想办法立即处理，到3月22日收到邮件大修，马不停蹄修改，4月4日修回，4月11日就显示reviews completed，然后就没消息了，催了一次说等编辑决定，2个月状态纹丝不动，到6月初又催了一次，回复跟上次一模一样，过了一天后居然又让推荐审稿人，迷之操作，看不懂了，推荐审稿人后继续等待，直到今晚突然收到邮件说接受了。等待过程比较辛苦，感觉是杂志社故意压稿，今年影响因子也降了，投此杂志的兄弟们准备好耐心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Wed Jun 14 23:51:39 CST 2023, time=2023-06-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2164215, encodeId=f8c2216421525, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：气死。等待分配编辑等了1个多月，近2月，发邮件要求退稿，才给分配了编辑。完了送外审，又快2月，说找不到审稿人，拒了。耽搁我4个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c444693051, createdName=1874229beam, createdTime=Sun Oct 22 16:45:36 CST 2023, time=2023-10-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2167525, encodeId=4857216e52535, content=偏重的研究方向：男性生殖 经验分享：记录一下这本杂志的第一次投稿，11.6投稿，目前还是new submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb5b5613243, createdName=ms5000001721638337, createdTime=Thu Nov 09 09:36:45 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2158272, encodeId=2a9521582e204, content=偏重的研究方向：肿瘤学 经验分享：大修返回去一周了还是under review,接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=ms5000000710567195, createdTime=Mon Sep 18 12:44:26 CST 2023, time=2023-09-18, status=1, ipAttribution=安徽省)]

2023-03-03 4382035_3828 来自广东省

偏重的研究方向：转化医学;translational medicine
经验分享：太坑了！！！23.01.22投稿，但今天23.03.03，还在那editor assigned呢！！！！期间催了三次，分别是半月，一月和今天，都是个V开头的名字回的邮件，查了下，可能是个助理编辑，印度人，回复内容大意就是就说sorry，ok，我向上转达......然后实际啥也没干还在这editor assigned呢...再等一周，不送我就主动撤稿！！！！好气啊！！！！！！！！！！！！！！！！！！！

52 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2175309, encodeId=41f921e5309d0, content=偏重的研究方向：cancer therapy;肿瘤;实验验证 经验分享：已经24天了，还是editor assigned。编号9600多号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Dec 16 18:35:26 CST 2023, time=2023-12-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175811, encodeId=cfa321e581135, content=偏重的研究方向：GWAS;心血管 经验分享：记录一下这个期刊的投稿经历。 先投了BMC medicine，三天光速拒稿，再投了Genome Medicine 十天建议转投。 12月14号投这个，现在12月19号还是new submission，是不是完全不感兴趣一直拖着我了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ee9080824, createdName=ms6000001245656875, createdTime=Tue Dec 19 14:19:10 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174662, encodeId=bb3721e46621a, content=偏重的研究方向：综述 经验分享：求meta投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a299060417, createdName=ms7000000984089298, createdTime=Wed Dec 13 10:11:26 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117409, encodeId=c06d211e409ea, content=偏重的研究方向：转化医学;translational medicine 经验分享：太坑了！！！23.01.22投稿，但今天23.03.03，还在那editor assigned呢！！！！期间催了三次，分别是半月，一月和今天，都是个V开头的名字回的邮件，查了下，可能是个助理编辑，印度人，回复内容大意就是就说sorry，ok，我向上转达......然后实际啥也没干还在这editor assigned呢...再等一周，不送我就主动撤稿！！！！好气啊！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c86436029, createdName=4382035_3828, createdTime=Fri Mar 03 22:27:08 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170659, encodeId=0e2121e0659ed, content=截至日期延后两天提交有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e71b1678189, createdName=周医生8433, createdTime=Fri Nov 24 08:48:54 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167495, encodeId=af8c216e495f3, content=求助，这个杂志的new submition一般持续多久到editor assigned呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Nov 09 04:10:01 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142837, encodeId=1968214283ec4, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：今天晚上刚收到accepted的邮件，投这个杂志真的需要耐心，虽然有的人很快接收，但我等的真心累。去年11月14日投稿，到今年3月初都没消息，忍不住发邮件催稿，得到回复没有足够审稿人，他们想办法立即处理，到3月22日收到邮件大修，马不停蹄修改，4月4日修回，4月11日就显示reviews completed，然后就没消息了，催了一次说等编辑决定，2个月状态纹丝不动，到6月初又催了一次，回复跟上次一模一样，过了一天后居然又让推荐审稿人，迷之操作，看不懂了，推荐审稿人后继续等待，直到今晚突然收到邮件说接受了。等待过程比较辛苦，感觉是杂志社故意压稿，今年影响因子也降了，投此杂志的兄弟们准备好耐心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Wed Jun 14 23:51:39 CST 2023, time=2023-06-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2164215, encodeId=f8c2216421525, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：气死。等待分配编辑等了1个多月，近2月，发邮件要求退稿，才给分配了编辑。完了送外审，又快2月，说找不到审稿人，拒了。耽搁我4个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c444693051, createdName=1874229beam, createdTime=Sun Oct 22 16:45:36 CST 2023, time=2023-10-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2167525, encodeId=4857216e52535, content=偏重的研究方向：男性生殖 经验分享：记录一下这本杂志的第一次投稿，11.6投稿，目前还是new submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb5b5613243, createdName=ms5000001721638337, createdTime=Thu Nov 09 09:36:45 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2158272, encodeId=2a9521582e204, content=偏重的研究方向：肿瘤学 经验分享：大修返回去一周了还是under review,接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=ms5000000710567195, createdTime=Mon Sep 18 12:44:26 CST 2023, time=2023-09-18, status=1, ipAttribution=安徽省)]

2023-11-24 周医生8433 来自广东省

截至日期延后两天提交有影响吗？

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2175309, encodeId=41f921e5309d0, content=偏重的研究方向：cancer therapy;肿瘤;实验验证 经验分享：已经24天了，还是editor assigned。编号9600多号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Dec 16 18:35:26 CST 2023, time=2023-12-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175811, encodeId=cfa321e581135, content=偏重的研究方向：GWAS;心血管 经验分享：记录一下这个期刊的投稿经历。 先投了BMC medicine，三天光速拒稿，再投了Genome Medicine 十天建议转投。 12月14号投这个，现在12月19号还是new submission，是不是完全不感兴趣一直拖着我了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ee9080824, createdName=ms6000001245656875, createdTime=Tue Dec 19 14:19:10 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174662, encodeId=bb3721e46621a, content=偏重的研究方向：综述 经验分享：求meta投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a299060417, createdName=ms7000000984089298, createdTime=Wed Dec 13 10:11:26 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117409, encodeId=c06d211e409ea, content=偏重的研究方向：转化医学;translational medicine 经验分享：太坑了！！！23.01.22投稿，但今天23.03.03，还在那editor assigned呢！！！！期间催了三次，分别是半月，一月和今天，都是个V开头的名字回的邮件，查了下，可能是个助理编辑，印度人，回复内容大意就是就说sorry，ok，我向上转达......然后实际啥也没干还在这editor assigned呢...再等一周，不送我就主动撤稿！！！！好气啊！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c86436029, createdName=4382035_3828, createdTime=Fri Mar 03 22:27:08 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170659, encodeId=0e2121e0659ed, content=截至日期延后两天提交有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e71b1678189, createdName=周医生8433, createdTime=Fri Nov 24 08:48:54 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167495, encodeId=af8c216e495f3, content=求助，这个杂志的new submition一般持续多久到editor assigned呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Nov 09 04:10:01 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142837, encodeId=1968214283ec4, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：今天晚上刚收到accepted的邮件，投这个杂志真的需要耐心，虽然有的人很快接收，但我等的真心累。去年11月14日投稿，到今年3月初都没消息，忍不住发邮件催稿，得到回复没有足够审稿人，他们想办法立即处理，到3月22日收到邮件大修，马不停蹄修改，4月4日修回，4月11日就显示reviews completed，然后就没消息了，催了一次说等编辑决定，2个月状态纹丝不动，到6月初又催了一次，回复跟上次一模一样，过了一天后居然又让推荐审稿人，迷之操作，看不懂了，推荐审稿人后继续等待，直到今晚突然收到邮件说接受了。等待过程比较辛苦，感觉是杂志社故意压稿，今年影响因子也降了，投此杂志的兄弟们准备好耐心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Wed Jun 14 23:51:39 CST 2023, time=2023-06-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2164215, encodeId=f8c2216421525, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：气死。等待分配编辑等了1个多月，近2月，发邮件要求退稿，才给分配了编辑。完了送外审，又快2月，说找不到审稿人，拒了。耽搁我4个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c444693051, createdName=1874229beam, createdTime=Sun Oct 22 16:45:36 CST 2023, time=2023-10-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2167525, encodeId=4857216e52535, content=偏重的研究方向：男性生殖 经验分享：记录一下这本杂志的第一次投稿，11.6投稿，目前还是new submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb5b5613243, createdName=ms5000001721638337, createdTime=Thu Nov 09 09:36:45 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2158272, encodeId=2a9521582e204, content=偏重的研究方向：肿瘤学 经验分享：大修返回去一周了还是under review,接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=ms5000000710567195, createdTime=Mon Sep 18 12:44:26 CST 2023, time=2023-09-18, status=1, ipAttribution=安徽省)]

2023-11-09 1240adaem89暂无昵称来自四川省

求助，这个杂志的new submition一般持续多久到editor assigned呀？

44 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2175309, encodeId=41f921e5309d0, content=偏重的研究方向：cancer therapy;肿瘤;实验验证 经验分享：已经24天了，还是editor assigned。编号9600多号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Dec 16 18:35:26 CST 2023, time=2023-12-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175811, encodeId=cfa321e581135, content=偏重的研究方向：GWAS;心血管 经验分享：记录一下这个期刊的投稿经历。 先投了BMC medicine，三天光速拒稿，再投了Genome Medicine 十天建议转投。 12月14号投这个，现在12月19号还是new submission，是不是完全不感兴趣一直拖着我了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ee9080824, createdName=ms6000001245656875, createdTime=Tue Dec 19 14:19:10 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174662, encodeId=bb3721e46621a, content=偏重的研究方向：综述 经验分享：求meta投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a299060417, createdName=ms7000000984089298, createdTime=Wed Dec 13 10:11:26 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117409, encodeId=c06d211e409ea, content=偏重的研究方向：转化医学;translational medicine 经验分享：太坑了！！！23.01.22投稿，但今天23.03.03，还在那editor assigned呢！！！！期间催了三次，分别是半月，一月和今天，都是个V开头的名字回的邮件，查了下，可能是个助理编辑，印度人，回复内容大意就是就说sorry，ok，我向上转达......然后实际啥也没干还在这editor assigned呢...再等一周，不送我就主动撤稿！！！！好气啊！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c86436029, createdName=4382035_3828, createdTime=Fri Mar 03 22:27:08 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170659, encodeId=0e2121e0659ed, content=截至日期延后两天提交有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e71b1678189, createdName=周医生8433, createdTime=Fri Nov 24 08:48:54 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167495, encodeId=af8c216e495f3, content=求助，这个杂志的new submition一般持续多久到editor assigned呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Nov 09 04:10:01 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142837, encodeId=1968214283ec4, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：今天晚上刚收到accepted的邮件，投这个杂志真的需要耐心，虽然有的人很快接收，但我等的真心累。去年11月14日投稿，到今年3月初都没消息，忍不住发邮件催稿，得到回复没有足够审稿人，他们想办法立即处理，到3月22日收到邮件大修，马不停蹄修改，4月4日修回，4月11日就显示reviews completed，然后就没消息了，催了一次说等编辑决定，2个月状态纹丝不动，到6月初又催了一次，回复跟上次一模一样，过了一天后居然又让推荐审稿人，迷之操作，看不懂了，推荐审稿人后继续等待，直到今晚突然收到邮件说接受了。等待过程比较辛苦，感觉是杂志社故意压稿，今年影响因子也降了，投此杂志的兄弟们准备好耐心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Wed Jun 14 23:51:39 CST 2023, time=2023-06-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2164215, encodeId=f8c2216421525, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：气死。等待分配编辑等了1个多月，近2月，发邮件要求退稿，才给分配了编辑。完了送外审，又快2月，说找不到审稿人，拒了。耽搁我4个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c444693051, createdName=1874229beam, createdTime=Sun Oct 22 16:45:36 CST 2023, time=2023-10-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2167525, encodeId=4857216e52535, content=偏重的研究方向：男性生殖 经验分享：记录一下这本杂志的第一次投稿，11.6投稿，目前还是new submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb5b5613243, createdName=ms5000001721638337, createdTime=Thu Nov 09 09:36:45 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2158272, encodeId=2a9521582e204, content=偏重的研究方向：肿瘤学 经验分享：大修返回去一周了还是under review,接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=ms5000000710567195, createdTime=Mon Sep 18 12:44:26 CST 2023, time=2023-09-18, status=1, ipAttribution=安徽省)]

2023-06-14 拉丁神曲来自陕西省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;临床
经验分享：今天晚上刚收到accepted的邮件，投这个杂志真的需要耐心，虽然有的人很快接收，但我等的真心累。去年11月14日投稿，到今年3月初都没消息，忍不住发邮件催稿，得到回复没有足够审稿人，他们想办法立即处理，到3月22日收到邮件大修，马不停蹄修改，4月4日修回，4月11日就显示reviews completed，然后就没消息了，催了一次说等编辑决定，2个月状态纹丝不动，到6月初又催了一次，回复跟上次一模一样，过了一天后居然又让推荐审稿人，迷之操作，看不懂了，推荐审稿人后继续等待，直到今晚突然收到邮件说接受了。等待过程比较辛苦，感觉是杂志社故意压稿，今年影响因子也降了，投此杂志的兄弟们准备好耐心吧

155 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2175309, encodeId=41f921e5309d0, content=偏重的研究方向：cancer therapy;肿瘤;实验验证 经验分享：已经24天了，还是editor assigned。编号9600多号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Dec 16 18:35:26 CST 2023, time=2023-12-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175811, encodeId=cfa321e581135, content=偏重的研究方向：GWAS;心血管 经验分享：记录一下这个期刊的投稿经历。 先投了BMC medicine，三天光速拒稿，再投了Genome Medicine 十天建议转投。 12月14号投这个，现在12月19号还是new submission，是不是完全不感兴趣一直拖着我了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ee9080824, createdName=ms6000001245656875, createdTime=Tue Dec 19 14:19:10 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174662, encodeId=bb3721e46621a, content=偏重的研究方向：综述 经验分享：求meta投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a299060417, createdName=ms7000000984089298, createdTime=Wed Dec 13 10:11:26 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117409, encodeId=c06d211e409ea, content=偏重的研究方向：转化医学;translational medicine 经验分享：太坑了！！！23.01.22投稿，但今天23.03.03，还在那editor assigned呢！！！！期间催了三次，分别是半月，一月和今天，都是个V开头的名字回的邮件，查了下，可能是个助理编辑，印度人，回复内容大意就是就说sorry，ok，我向上转达......然后实际啥也没干还在这editor assigned呢...再等一周，不送我就主动撤稿！！！！好气啊！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c86436029, createdName=4382035_3828, createdTime=Fri Mar 03 22:27:08 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170659, encodeId=0e2121e0659ed, content=截至日期延后两天提交有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e71b1678189, createdName=周医生8433, createdTime=Fri Nov 24 08:48:54 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167495, encodeId=af8c216e495f3, content=求助，这个杂志的new submition一般持续多久到editor assigned呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Nov 09 04:10:01 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142837, encodeId=1968214283ec4, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：今天晚上刚收到accepted的邮件，投这个杂志真的需要耐心，虽然有的人很快接收，但我等的真心累。去年11月14日投稿，到今年3月初都没消息，忍不住发邮件催稿，得到回复没有足够审稿人，他们想办法立即处理，到3月22日收到邮件大修，马不停蹄修改，4月4日修回，4月11日就显示reviews completed，然后就没消息了，催了一次说等编辑决定，2个月状态纹丝不动，到6月初又催了一次，回复跟上次一模一样，过了一天后居然又让推荐审稿人，迷之操作，看不懂了，推荐审稿人后继续等待，直到今晚突然收到邮件说接受了。等待过程比较辛苦，感觉是杂志社故意压稿，今年影响因子也降了，投此杂志的兄弟们准备好耐心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Wed Jun 14 23:51:39 CST 2023, time=2023-06-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2164215, encodeId=f8c2216421525, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：气死。等待分配编辑等了1个多月，近2月，发邮件要求退稿，才给分配了编辑。完了送外审，又快2月，说找不到审稿人，拒了。耽搁我4个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c444693051, createdName=1874229beam, createdTime=Sun Oct 22 16:45:36 CST 2023, time=2023-10-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2167525, encodeId=4857216e52535, content=偏重的研究方向：男性生殖 经验分享：记录一下这本杂志的第一次投稿，11.6投稿，目前还是new submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb5b5613243, createdName=ms5000001721638337, createdTime=Thu Nov 09 09:36:45 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2158272, encodeId=2a9521582e204, content=偏重的研究方向：肿瘤学 经验分享：大修返回去一周了还是under review,接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=ms5000000710567195, createdTime=Mon Sep 18 12:44:26 CST 2023, time=2023-09-18, status=1, ipAttribution=安徽省)]

2023-10-22 1874229beam 来自陕西省

审稿速度:6.0
偏重的研究方向：肿瘤;生信
经验分享：气死。等待分配编辑等了1个多月，近2月，发邮件要求退稿，才给分配了编辑。完了送外审，又快2月，说找不到审稿人，拒了。耽搁我4个多月。

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2175309, encodeId=41f921e5309d0, content=偏重的研究方向：cancer therapy;肿瘤;实验验证 经验分享：已经24天了，还是editor assigned。编号9600多号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Dec 16 18:35:26 CST 2023, time=2023-12-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175811, encodeId=cfa321e581135, content=偏重的研究方向：GWAS;心血管 经验分享：记录一下这个期刊的投稿经历。 先投了BMC medicine，三天光速拒稿，再投了Genome Medicine 十天建议转投。 12月14号投这个，现在12月19号还是new submission，是不是完全不感兴趣一直拖着我了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ee9080824, createdName=ms6000001245656875, createdTime=Tue Dec 19 14:19:10 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174662, encodeId=bb3721e46621a, content=偏重的研究方向：综述 经验分享：求meta投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a299060417, createdName=ms7000000984089298, createdTime=Wed Dec 13 10:11:26 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117409, encodeId=c06d211e409ea, content=偏重的研究方向：转化医学;translational medicine 经验分享：太坑了！！！23.01.22投稿，但今天23.03.03，还在那editor assigned呢！！！！期间催了三次，分别是半月，一月和今天，都是个V开头的名字回的邮件，查了下，可能是个助理编辑，印度人，回复内容大意就是就说sorry，ok，我向上转达......然后实际啥也没干还在这editor assigned呢...再等一周，不送我就主动撤稿！！！！好气啊！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c86436029, createdName=4382035_3828, createdTime=Fri Mar 03 22:27:08 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170659, encodeId=0e2121e0659ed, content=截至日期延后两天提交有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e71b1678189, createdName=周医生8433, createdTime=Fri Nov 24 08:48:54 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167495, encodeId=af8c216e495f3, content=求助，这个杂志的new submition一般持续多久到editor assigned呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Nov 09 04:10:01 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142837, encodeId=1968214283ec4, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：今天晚上刚收到accepted的邮件，投这个杂志真的需要耐心，虽然有的人很快接收，但我等的真心累。去年11月14日投稿，到今年3月初都没消息，忍不住发邮件催稿，得到回复没有足够审稿人，他们想办法立即处理，到3月22日收到邮件大修，马不停蹄修改，4月4日修回，4月11日就显示reviews completed，然后就没消息了，催了一次说等编辑决定，2个月状态纹丝不动，到6月初又催了一次，回复跟上次一模一样，过了一天后居然又让推荐审稿人，迷之操作，看不懂了，推荐审稿人后继续等待，直到今晚突然收到邮件说接受了。等待过程比较辛苦，感觉是杂志社故意压稿，今年影响因子也降了，投此杂志的兄弟们准备好耐心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Wed Jun 14 23:51:39 CST 2023, time=2023-06-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2164215, encodeId=f8c2216421525, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：气死。等待分配编辑等了1个多月，近2月，发邮件要求退稿，才给分配了编辑。完了送外审，又快2月，说找不到审稿人，拒了。耽搁我4个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c444693051, createdName=1874229beam, createdTime=Sun Oct 22 16:45:36 CST 2023, time=2023-10-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2167525, encodeId=4857216e52535, content=偏重的研究方向：男性生殖 经验分享：记录一下这本杂志的第一次投稿，11.6投稿，目前还是new submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb5b5613243, createdName=ms5000001721638337, createdTime=Thu Nov 09 09:36:45 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2158272, encodeId=2a9521582e204, content=偏重的研究方向：肿瘤学 经验分享：大修返回去一周了还是under review,接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=ms5000000710567195, createdTime=Mon Sep 18 12:44:26 CST 2023, time=2023-09-18, status=1, ipAttribution=安徽省)]

2023-11-09 ms5000001721638337 来自四川省

偏重的研究方向：男性生殖
经验分享：记录一下这本杂志的第一次投稿，11.6投稿，目前还是new submission

19 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2175309, encodeId=41f921e5309d0, content=偏重的研究方向：cancer therapy;肿瘤;实验验证 经验分享：已经24天了，还是editor assigned。编号9600多号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Dec 16 18:35:26 CST 2023, time=2023-12-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175811, encodeId=cfa321e581135, content=偏重的研究方向：GWAS;心血管 经验分享：记录一下这个期刊的投稿经历。 先投了BMC medicine，三天光速拒稿，再投了Genome Medicine 十天建议转投。 12月14号投这个，现在12月19号还是new submission，是不是完全不感兴趣一直拖着我了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ee9080824, createdName=ms6000001245656875, createdTime=Tue Dec 19 14:19:10 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174662, encodeId=bb3721e46621a, content=偏重的研究方向：综述 经验分享：求meta投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a299060417, createdName=ms7000000984089298, createdTime=Wed Dec 13 10:11:26 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117409, encodeId=c06d211e409ea, content=偏重的研究方向：转化医学;translational medicine 经验分享：太坑了！！！23.01.22投稿，但今天23.03.03，还在那editor assigned呢！！！！期间催了三次，分别是半月，一月和今天，都是个V开头的名字回的邮件，查了下，可能是个助理编辑，印度人，回复内容大意就是就说sorry，ok，我向上转达......然后实际啥也没干还在这editor assigned呢...再等一周，不送我就主动撤稿！！！！好气啊！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c86436029, createdName=4382035_3828, createdTime=Fri Mar 03 22:27:08 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170659, encodeId=0e2121e0659ed, content=截至日期延后两天提交有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e71b1678189, createdName=周医生8433, createdTime=Fri Nov 24 08:48:54 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167495, encodeId=af8c216e495f3, content=求助，这个杂志的new submition一般持续多久到editor assigned呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Nov 09 04:10:01 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142837, encodeId=1968214283ec4, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：今天晚上刚收到accepted的邮件，投这个杂志真的需要耐心，虽然有的人很快接收，但我等的真心累。去年11月14日投稿，到今年3月初都没消息，忍不住发邮件催稿，得到回复没有足够审稿人，他们想办法立即处理，到3月22日收到邮件大修，马不停蹄修改，4月4日修回，4月11日就显示reviews completed，然后就没消息了，催了一次说等编辑决定，2个月状态纹丝不动，到6月初又催了一次，回复跟上次一模一样，过了一天后居然又让推荐审稿人，迷之操作，看不懂了，推荐审稿人后继续等待，直到今晚突然收到邮件说接受了。等待过程比较辛苦，感觉是杂志社故意压稿，今年影响因子也降了，投此杂志的兄弟们准备好耐心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Wed Jun 14 23:51:39 CST 2023, time=2023-06-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2164215, encodeId=f8c2216421525, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：气死。等待分配编辑等了1个多月，近2月，发邮件要求退稿，才给分配了编辑。完了送外审，又快2月，说找不到审稿人，拒了。耽搁我4个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c444693051, createdName=1874229beam, createdTime=Sun Oct 22 16:45:36 CST 2023, time=2023-10-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2167525, encodeId=4857216e52535, content=偏重的研究方向：男性生殖 经验分享：记录一下这本杂志的第一次投稿，11.6投稿，目前还是new submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb5b5613243, createdName=ms5000001721638337, createdTime=Thu Nov 09 09:36:45 CST 2023, time=2023-11-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2158272, encodeId=2a9521582e204, content=偏重的研究方向：肿瘤学 经验分享：大修返回去一周了还是under review,接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=ms5000000710567195, createdTime=Mon Sep 18 12:44:26 CST 2023, time=2023-09-18, status=1, ipAttribution=安徽省)]

2023-09-18 ms5000000710567195 来自安徽省

偏重的研究方向：肿瘤学
经验分享：大修返回去一周了还是under review,接accept!

29 15

展开15条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务